Efficacy of erenumab (AMG 334) in chronic migraine patients with prior prophylactic treatment failure: Subgroup analysis of the phase 2, randomised, double-blind, placebo-controlled study

被引:0
|
作者
Ashina, Messoud [1 ,2 ,3 ]
Tepper, Stewart J. [4 ]
Brandes, Jan Lewis [5 ,6 ]
Reuter, Uwe [7 ]
Boudreau, Guy P. [8 ]
Dolezil, David [9 ]
Cheng, Sunfa [10 ]
Leonardi, Dean [10 ]
Lenz, Robert A. [10 ]
Klatt, Jan [11 ]
Mikol, Daniel D. [10 ]
机构
[1] Rigshosp, Danish Headache Ctr, Glostrup, Denmark
[2] Rigshosp, Dept Neurol, Glostrup, Denmark
[3] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark
[4] Geisel Sch Med Dartmouth, Hanover, NH USA
[5] Nashville Neurosci Grp, Nashville, TN USA
[6] Vanderbilt Univ, Sch Neurol, Nashville, TN 37235 USA
[7] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[8] Univ Hosp Ctr Montreal, Neurol Dept, Headache Unit, Montreal, PQ, Canada
[9] DADO Med Sro, Prague Headache Ctr, Prague, Czech Republic
[10] Amgen Inc, Thousand Oaks, CA 91320 USA
[11] Novartis Pharma AG, Basel, Switzerland
来源
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P6
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Busse, W. W.
    Wenzel, S. E.
    Meltzer, E. O.
    Kerwin, E. M.
    Liu, M. C.
    Zhang, N.
    Chon, Y.
    Lin, J.
    Lin, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
  • [42] Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
    Croop, Robert
    Lipton, Richard B.
    Kudrow, David
    Stock, David A.
    Kamen, Lisa
    Conway, Charles M.
    Stock, Elyse G.
    Coric, Vladimir
    Goadsby, Peter J.
    LANCET, 2021, 397 (10268): : 51 - 60
  • [43] Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study
    Andersen, Anne Sofie Schott
    Maarbjerg, Stine
    Noory, Navid
    Heinskou, Tone Bruvik
    Forman, Julie Lyng
    Cruccu, Giorgio
    Ashina, Messoud
    Bendtsen, Lars
    LANCET NEUROLOGY, 2022, 21 (11): : 994 - 1003
  • [44] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
    Silberstein, Stephen D.
    Lipton, Richard B.
    Dodick, David W.
    Freitag, Frederick G.
    Ramadan, Nabih
    Mathew, Ninan
    Brandes, Jan L.
    Bigal, Marcelo
    Saper, Joel
    Ascher, Steven
    Jordan, Donna M.
    Greenberg, Steven J.
    Hulihan, Joseph
    HEADACHE, 2007, 47 (02): : 170 - 180
  • [45] Single-Dose and Multiple Dose, Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of AMG 334 in Healthy Subjects and Migraine Patients
    de Hoon, J. N.
    Van Hecken, A.
    Yan, L.
    Smith, B.
    Chen, J.
    Bautista, E.
    Hamilton, L.
    Waksman, J.
    Vu, T.
    Vargas, G.
    HEADACHE, 2015, 55 : 174 - 175
  • [46] Repetitive transcranial magnetic stimulation (rTMS) in the prophylactic treatment of chronic migraine: a double-blind, randomized, placebo-controlled study
    Libera, D. Dalla
    Colombo, B.
    Nuara, A.
    Straffi, L.
    Spagnolo, F.
    Fichera, M.
    Coppi, E.
    Ferrari, L.
    Di Maggio, G.
    Houdayer, E.
    Chieffo, R.
    Zangen, A.
    Comi, G.
    Leocani, L.
    JOURNAL OF NEUROLOGY, 2013, 260 : S199 - S200
  • [47] Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
    Bigal, Marcelo E.
    Edvinsson, Lars
    Rapoport, Alan M.
    Lipton, Richard B.
    Spierings, Egilius L. H.
    Diener, Hans-Christoph
    Burstein, Rami
    Loupe, Pippa S.
    Ma, Yuju
    Yang, Ronghua
    Silberstein, Stephen D.
    LANCET NEUROLOGY, 2015, 14 (11): : 1091 - 1100
  • [48] Levetiracetam for prophylactic treatment of pediatric migraine: A randomized double-blind placebo-controlled trial
    Montazerlotfelahi, Hadi
    Amanat, Man
    Tavasoli, Ali Reza
    Agah, Elmira
    Zamani, Gholam Reza
    Sander, Josemir W.
    Badv, Reza Shervin
    Mohammadi, Mahmoud
    Dehghani, Mahdieh
    Heidari, Morteza
    Hosseini, Seyed Ahmad
    Salehi, Mona
    Ashrafi, Mahmoud Reza
    CEPHALALGIA, 2019, 39 (12) : 1509 - 1517
  • [49] Tricaprilin (CER-0001) for the preventive treatment of migraine: A phase 2 randomised, double-blind, placebo-controlled pilot study
    Chow, Lilian
    Presanis, Julia
    Mcintyre, Nikki
    Henderson, Samuel
    Bloch, Mark
    Hutton, Elspeth
    Cantillon, Marc
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 464
  • [50] Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies
    Evers, S.
    Marziniak, M.
    Frese, A.
    Gralow, I.
    CEPHALALGIA, 2009, 29 (04) : 436 - 444